RGTI Form 4: Director Clifton Discloses 21,188 Warrants Executed Under 10b5-1
Rhea-AI Filing Summary
Rigetti Computing, Inc. (RGTI) Form 4: Michael S. Clifton, a director, reported transactions dated 08/14/2025 executed pursuant to a Rule 10b5-1 trading plan adopted March 10, 2025. The filing discloses activity in warrants with a stated conversion/exercise price of $11.50 and 21,188 underlying common shares linked to those derivatives. The form notes the warrants are fully vested and exercisable. The Form 4 was signed by an attorney-in-fact on 08/15/2025. The reporting person is identified with an address at Rigetti Computing, Inc., Berkeley, CA, and is marked as a Director.
Positive
- Transaction executed under a Rule 10b5-1 plan, indicating pre-established trading terms and potential compliance with insider-trading defenses
- Warrants are fully vested and exercisable, clarifying the reporting person's ability to transact
Negative
- None.
Insights
TL;DR: Routine insider derivative exercise/sale under a pre-established 10b5-1 plan; no new material disclosures beyond quantity and plan adoption date.
The filing documents a director-level reporting person executing transactions on 08/14/2025 under a Rule 10b5-1 plan adopted March 10, 2025. The report lists 21,188 warrants tied to the same number of common shares and shows an exercise/conversion price of $11.50. The derivatives are described as fully vested and exercisable. The use of a 10b5-1 plan and attorney-in-fact signature are consistent with pre-arranged insider trading procedures. This appears to be an operational insider transaction disclosure rather than a corporate event impacting company fundamentals.
TL;DR: Disclosure follows standard Section 16/Form 4 practice; shows a director used a documented 10b5-1 plan and granted power-of-attorney for filing.
The Form 4 identifies Michael S. Clifton as a director and indicates the transaction was made pursuant to a 10b5-1 plan adopted on March 10, 2025. The filing includes an attorney-in-fact signature dated 08/15/2025. The notice states the warrants are fully vested and exercisable. From a governance perspective, using a documented trading plan and attorney-in-fact for execution aligns with accepted insider trading compliance procedures. The filing does not disclose any change in board status or other governance actions.
FAQ
What did Michael S. Clifton report on the Form 4 for RGTI?
Was the transaction part of a 10b5-1 trading plan for RGTI?
How many warrants and underlying shares were involved in the reported transaction?
What exercise or conversion price is disclosed in the Form 4?
Who signed the Form 4 and when?